1. HOME
2. Research Insight
3. Thermo Fisher Scientific Inc. (US) and Merck KGaA (Germany) are Leading Players in the Research Antibodies & Reagents Market

The research antibodies and reagents market are projected to reach USD 16.2 billion by 2028 from USD 11.8 billion in 2023, at a CAGR of 6.5% during the forecast period. Factors such as the emergence of Antibody-Drug Conjugate (ADCs) has created a new revenue pocket for research antibodies and reagents companies. Also, pharmaceutical and life science companies are helping university researchers by providing technical and financial assistance to commercialize university research projects. Such developments are expected to have a positive impact on the growth of the research antibodies and reagents market during the forecast period.

The global research antibodies and reagents market is highly competitive and fragmented.  The top players are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), BD (US), and Revvity (US). The top market players have adopted various strategies such as new product launches, acquisitions, collaborations, and geographical expansions to strengthen their position in the global research antibodies and reagents market.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher offers a wide range of research reagents and antibodies, including primary and secondary antibodies, buffers, stains & dyes, chemicals, and media. Thermo Fisher has also been successful in dominating the research antibodies and reagents market since its strategic acquisition of Invitrogen, which was one of the leading suppliers of antibodies and other research reagents. This acquisition gave Thermo Fisher a significant market share in the research antibodies and reagents market. Currently, the company offers a wide range of research products, including more than 40,000 high-quality primary and secondary antibodies, along with a wide range of reagents. The company invests heavily in research and development, which allows the company to develop new and innovative products. This helps Thermo Fisher to stay ahead of the competition.

The company’s wide presence worldwide has also played an essential role in securing its position in the market. To maintain its leading position and enhance its market share, the company mainly focuses on exceeding customer expectations by maintaining the quality of its products and quickly & efficiently adapting to new conditions.

Merck KGaA (Germany)

Merck KGaA is a leading life sciences company offering research antibodies and reagents for academic, biopharmaceutical, and industrial sectors. The company strategically positions itself in key areas of the market, leveraging its expertise and offerings to meet the demands of proteomics and genomics research, which are growing fields in the life sciences. Merck is a leading developer of high-quality antibodies that have been validated for use in immunostaining, blotting, purification, ChIP, flow cytometry, and multiplexed assays. The company is also investing a large sum in project expansion to increase its production capacity and cater to a more extensive consumer base. In June 2023, Merck invested USD 73.7 million to expand the production capacity for highly purified reagents at its site in Nantong, China. North America and Europe contribute about 70% of the company’s total business. Merck also focuses on acquisitions and agreements as its key growth strategies.

Agilent Technologies, Inc. (US)

Agilent is a leading player in the market, offering products that are used in a variety of applications, including research and development, quality control, and manufacturing. Agilent's OEM partnership program enables other companies to incorporate Agilent's research antibodies and reagents into its products and services. This program benefits both Agilent and its partners, and it is helping to strengthen Agilent's position in the research antibodies and reagents market. Overall, the OEM partnership program is a strategic initiative that is assisting Agilent to expand its position in the research antibodies and reagents market.

Related Reports:

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]